44 related articles for article (PubMed ID: 1685551)
1. Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein.
Cumber PM; Jacobs A; Hoy T; Whittaker JA; Tsuruo T; Padua RA
Leukemia; 1991 Dec; 5(12):1050-3. PubMed ID: 1685551
[TBL] [Abstract][Full Text] [Related]
2. Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia.
Xie XY; Robb D; Chow S; Hedley DW
Leukemia; 1995 Nov; 9(11):1882-7. PubMed ID: 7475279
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
Van Acker KL; Van Hove LM; Boogaerts MA
Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
[TBL] [Abstract][Full Text] [Related]
4. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
Gollapudi S; Gupta S
Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
6. Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
Marie JP; Faussat-Suberville AM; Zhou D; Zittoun R
Leukemia; 1993 Jun; 7(6):825-31. PubMed ID: 8099135
[TBL] [Abstract][Full Text] [Related]
7. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
8. [Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16, and their synergistic modulation of multidrug resistance].
Naito M; Tsuruo T
Gan To Kagaku Ryoho; 1994 Feb; 21(3):395-402. PubMed ID: 7906507
[TBL] [Abstract][Full Text] [Related]
9. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
Piwnica-Worms D; Chiu ML; Budding M; Kronauge JF; Kramer RA; Croop JM
Cancer Res; 1993 Mar; 53(5):977-84. PubMed ID: 8094997
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
[TBL] [Abstract][Full Text] [Related]
11. A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells.
Gruber A; Larsson R; Nygren P; Björkholm M; Peterson C
Leukemia; 1994 Jun; 8(6):985-9. PubMed ID: 7911547
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
13. Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia.
Cumber PM; Jacobs A; Hoy T; Fisher J; Whittaker JA; Tsuruo T; Padua RA
Br J Haematol; 1990 Oct; 76(2):226-30. PubMed ID: 1709806
[TBL] [Abstract][Full Text] [Related]
14. Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG.
Krasznai ZT; Tóth A; Mikecz P; Fodor Z; Szabó G; Galuska L; Hernádi Z; Goda K
Eur J Pharm Sci; 2010 Dec; 41(5):665-9. PubMed ID: 20869436
[TBL] [Abstract][Full Text] [Related]
15. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S
Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416
[TBL] [Abstract][Full Text] [Related]
17. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng.
Choi CH; Kang G; Min YD
Planta Med; 2003 Mar; 69(3):235-40. PubMed ID: 12677527
[TBL] [Abstract][Full Text] [Related]
18. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
Kavallaris M; Madafiglio J; Norris MD; Haber M
Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the reversal activity of SDZ PSC833 on multi-drug resistance by an anti-P-glycoprotein monoclonal antibody MRK-16.
Naito M; Watanabe T; Tsuge H; Koyama T; Oh-hara T; Tsuruo T
Int J Cancer; 1996 Jul; 67(3):435-40. PubMed ID: 8707421
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.
Naito M; Tsuge H; Kuroko C; Tomida A; Tsuruo T
Jpn J Cancer Res; 1993 May; 84(5):489-92. PubMed ID: 8100562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
